Moneycontrol
Get App
SENSEX NIFTY
you are here:

Biopac India Corporation Ltd.

BSE Live

Feb 14, 16:00
2.84 -0.01 (-0.35%)
Volume
AVERAGE VOLUME
5-Day
414
10-Day
509
30-Day
774
1,500
  • Prev. Close

    2.85

  • Open Price

    2.84

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

(%)
Volume
No Data Available
  • Prev. Close

  • Open Price

  • Bid Price (Qty.)

    ()

  • Offer Price (Qty.)

    ()

Biopac India Corporation is not listed on NSE

ANNOUNCEMENTS ON Biopac India

  • Jul 11, 2019 14:42 Source: BSE

    Biopac India Corporation - Shareholding for the Period Ended June 30, 2019

    Biopac India Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here

  • Jul 05, 2019 10:42 Source: BSE

    Biopac India Corporation - Announcement Under Regulation 30 (LODR)-Updates (Intimation For Default In Payment Of Loan Installment)

    Intimation for default in Payment of Loan Installment

  • Jun 29, 2019 14:16 Source: BSE

    Biopac India Corporation - Closure of Trading Window

    This is to inform you that as per the provisions of SEBl (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and Code of the Company, the Trading Window for dealing in the Securities of the Company for all the Designated Persons including insiders shall remain closed from 1st July, 2019 to till the end of 48 hours after the declaration of Un-audited Financial results for the First quarter ended on June 30, 2019. The date of the Board Meeting to consider the Un-audited Financial results for the First quarter ended on June 30, 2019, shall be intimated separately.

  • May 25, 2019 10:55 Source: BSE

    Biopac India Corporation - Reg.24(A)-Annual Secretarial Compliance

    Annual Secretarial Compliance Report

    Sr. No. Particulars Details
    1Period for which the report has been issued 31/03/2019
    2Date of Report21/05/2019
    3 Name of the Certifying Firm PRASHANT DIWAN
    4 Name of the Certifying Individual PRASHANT DIWAN
    5Membership TypeACS
    6 Membership Number 1403
    7 CP No. 1979
    8 Whether any observations/qualification reported by the Secretarial Auditor ? Yes


  • May 08, 2019 18:10 Source: BSE

    Biopac India Corporation - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, we enclose herewith copy of news papers cutting of Financial Express (English Newspaper) and Financial Express (Gujarati Newspaper) of Saturday, May 4, 2019 wherein following matter is being published: Extract of Audited Financial Results for the 4th quarter and the year ended 31st March, 2019.

  • May 03, 2019 17:59 Source: BSE

    Biopac India Corporation - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

    This is to inform you that pursuant to Regulation 30 and 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, the Board of Directors of the Company at its Meeting held on today i.e. Friday, the 3rd May, 2019 have approved and taken on record the following: 1. Audited Financial Results for the 4th Quarter and the year ended 31st March, 2019. 2. Resignation of Mr. Harish B. Doshi as Chief Financial Officer (CFO) of the Company w.e.f. May 3, 2019. Also Attached herewith following pursuant to Regulation 33(3)(d) of the SEBI(Listing Obligation and Disclosure Requirements) Regulation 2015. 1) Audited Financial Results for the 4th Quarter ended and the year ended 31st March, 2019 along with the statement of Assets and Liabilities as at the half year ended 31st March, 2019. 2) The Auditors'' Report on Financial Result and 3) Declaration by the Managing Director of the Company.

  • May 03, 2019 17:52 Source: BSE

    Biopac India Corporation - Results-Financial Results For March 31, 2019

    Results-Financial Results for March 31, 2019

  • May 03, 2019 17:46 Source: BSE

    Biopac India Corporation - Outcome of Board Meeting

    The Board of Directors of the Company at its Meeting held on today i.e. Friday, the 3rd May, 2019, have approved and taken on record the Audited Financial Results for the 4th Quarter and the year ended 31st March, 2019 Attached herewith following pursuant to Regulation 33(3)(d) of the SEBI(Listing Obligation and Disclosure Requirements) Regulation 2015. 1) Audited Financial Results for the 4th Quarter ended and the year ended 31st March, 2019 along with the statement of Assets and Liabilities as at the year ended 31st March, 2019. 2) The Auditors'''' Report on Financial Result and 3) Declaration by the Managing Director of the Company. 4) Letter dated 26.04.2019 in respect of resignation of Mr Harish Doshi from the post of CFO of the Company has been accepted by Board w.e.f.26.04.2019

  • Apr 30, 2019 17:35 Source: BSE

    Biopac India Corporation - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

    Sr. No. Particulars Details
    1Name of CompayBIOPAC INDIA CORPORATION LTD.-$
    2CININE998A01017
    3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 29
    4Highest Credit Rating during the previous FY NA
    4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
    5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE


    We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No



    Name of the Company Secretary: JIGAR BAGARIA
    Designation: Company Secretary & Compliance Officer
    EmailId: jigarbagaria92@gmail.com
    Name of the Chief Financial Officer: Harish Doshi
    Designation: Whole-time Director & CFO
    EmailId: hdoshi@biopacindia.com

    Date: 30/04/2019

    Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

  • Apr 30, 2019 17:17 Source: BSE

    Biopac India Corporation - Announcement under Regulation 30 (LODR)-Change in Corporate Office Address

    We would like to inform you that corporate office address has changed from 105, Kanakia Atrium 2, Next To Courtyard By Marriot Hotel, Chakala, Andheri (East), Mumbai - 400093 to Unit no. 802, Remi Commercio Building, Plot No.14, 8th Floor, Shah Industrial Estate, Off New Andheri Link Road, Andheri West, Mumbai - 400 053 w.e.f. 30th April, 2019. The new Telephone number of the Company will be 022-66950317 and 022-66950318. This is for your information and for the information of members of your exchange.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Feb 07, 2020
Remark : Quarterly Results